CDK9 antibody (N-Term)

Catalog No. ABIN926890

This Rabbit Polyclonal antibody specifically detects CDK9 in WB. It exhibits reactivity toward Human.

Quick Overview for CDK9 antibody (N-Term) (ABIN926890)

Target: CDK9 (Cyclin-Dependent Kinase 9 (CDK9))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CDK9 antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-CDK9 Antibody

Binding Specificity: N-Term

Purification: Purified

Immunogen: CDK9 antibody was raised in rabbit using the N terminal of CDK9 as the immunogen

Application Details

Application Notes: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for CDK9

Target: CDK9 (Cyclin-Dependent Kinase 9 (CDK9))

Alternative Name: CDK9

Background: CDK9 is the member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro. Synonyms: Polyclonal CDK9 antibody, Anti-CDK9 antibody, cyclin-dependent kinase 9 antibody, C-2k antibody, CDC2L4 antibody, PITALRE antibody, TAK antibody.

Pathways: Cell Division Cycle